1. Home
  2. GCMG vs CTKB Comparison

GCMG vs CTKB Comparison

Compare GCMG & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GCM Grosvenor Inc.

GCMG

GCM Grosvenor Inc.

HOLD

Current Price

$9.68

Market Cap

731.1M

Sector

Finance

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.54

Market Cap

652.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCMG
CTKB
Founded
1971
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
731.1M
652.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GCMG
CTKB
Price
$9.68
$4.54
Analyst Decision
Buy
Hold
Analyst Count
3
5
Target Price
$15.67
$5.70
AVG Volume (30 Days)
629.7K
706.8K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
4.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
$7.28
$5.42
Revenue Next Year
$11.70
$7.03
P/E Ratio
$28.21
N/A
Revenue Growth
N/A
17.67
52 Week Low
$9.52
$2.37
52 Week High
$13.48
$6.18

Technical Indicators

Market Signals
Indicator
GCMG
CTKB
Relative Strength Index (RSI) 33.49 55.97
Support Level N/A $4.56
Resistance Level $11.99 $5.24
Average True Range (ATR) 0.40 0.18
MACD -0.13 0.07
Stochastic Oscillator 10.32 80.00

Price Performance

Historical Comparison
GCMG
CTKB

About GCMG GCM Grosvenor Inc.

GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: